Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia
Clinical trial NCT00462332 · COMPLETED
Trial details
- NCT number
- NCT00462332
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2011-06-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.